RealTime Software Solutions Announces Acquisition of Devana Solutions
RealTime Software Solutions has announced its acquisition of Devana Solutions, an SaaS provider specializing in clinical trial workflow and analytics solutions.
By integrating Devana's solutions into RealTime's Site Operations Management System (SOMS), clinical research organizations will be able to access a suite of capabilities that bridge centralized operations with site-based clinical teams. The combination of these solutions establishes connectivity between Devana's business development and data analytics platform and RealTime's suite of products that includes CTMS, eRegulatory solutions, eSource, eConsent, payments, texting solutions, the MyStudyManager Participant Portal, and other eClinical solutions and services.
Originally designed to address the operational gap before participant recruitment, screening and CTMS-managed clinical workflows, Devana's PROPEL products automate pipeline management and trial startup workflows while capturing timing and performance metrics for analysis and action.
Reference
RealTime Software Solutions Strengthens its Position in the Clinical Research Industry with the Acquisition of Devana Solutions. (2023, July 6). Cision PR Newswire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
